Selected article for: "acid diagnosis and loss function"

Author: Bao, Guoqing; Chen, Huai; Liu, Tongliang; Gong, Guanzhong; Yin, Yong; Wang, Lisheng; Wang, Xiuying
Title: COVID-MTL: Multitask Learning with Shift3D and Random-weighted Loss for Automated Diagnosis and Severity Assessment of COVID-19
  • Cord-id: yuclqoj7
  • Document date: 2020_12_10
  • ID: yuclqoj7
    Snippet: There is an urgent need for automated methods to assist accurate and effective assessment of COVID-19. Radiology and nucleic acid test (NAT) are complementary COVID-19 diagnosis methods. In this paper, we present an end-to-end multitask learning (MTL) framework (COVID-MTL) that is capable of automated and simultaneous detection (against both radiology and NAT) and severity assessment of COVID-19. COVID-MTL learns different COVID-19 tasks in parallel through our novel random-weighted loss functio
    Document: There is an urgent need for automated methods to assist accurate and effective assessment of COVID-19. Radiology and nucleic acid test (NAT) are complementary COVID-19 diagnosis methods. In this paper, we present an end-to-end multitask learning (MTL) framework (COVID-MTL) that is capable of automated and simultaneous detection (against both radiology and NAT) and severity assessment of COVID-19. COVID-MTL learns different COVID-19 tasks in parallel through our novel random-weighted loss function, which assigns learning weights under Dirichlet distribution to prevent task dominance; our new 3D real-time augmentation algorithm (Shift3D) introduces space variances for 3D CNN components by shifting low-level feature representations of volumetric inputs in three dimensions; thereby, the MTL framework is able to accelerate convergence and improve joint learning performance compared to single-task models. By only using chest CT scans, COVID-MTL was trained on 930 CT scans and tested on separate 399 cases. COVID-MTL achieved AUCs of 0.939 and 0.846, and accuracies of 90.23% and 79.20% for detection of COVID-19 against radiology and NAT, respectively, which outperformed the state-of-the-art models. Meanwhile, COVID-MTL yielded AUC of 0.800 $\pm$ 0.020 and 0.813 $\pm$ 0.021 (with transfer learning) for classifying control/suspected, mild/regular, and severe/critically-ill cases. To decipher the recognition mechanism, we also identified high-throughput lung features that were significantly related (P<0.001) to the positivity and severity of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • loss function and lung appearance: 1
    • loss function and lung delineation: 1
    • loss function and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • loss function and lung feature: 1
    • loss function and lung imaging: 1
    • loss function and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • loss function and lung region: 1
    • loss function and lung segmentation: 1, 2, 3, 4, 5, 6
    • loss function and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • loss function and lung volume: 1, 2
    • loss function and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • loss function and machine learning model: 1, 2, 3
    • low learning and lung disease: 1, 2
    • low learning and lung segmentation: 1
    • low learning and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • low learning and machine learning model: 1, 2, 3, 4